文献速递心脑血管急症重症综合管理与镇静镇痛

血浆磷酸化tau(p-tau231)与总tau(t-tau)作为心脏骤停后神经功能预后标志物的多中心研究

Plasma phosphorylated tau (p-tau231) and total tau (t-tau) as prognostic markers of neurological outcome after cardiac arrest - a multicentre study.
PubMed 文献 · Resuscitation · 2024-12-03
一句话结论在心脏骤停后入住ICU的患者中,t-tau在48小时对神经功能预后的预测能力强于p-tau231,校正临床协变量后t-tau仍显著改善预后模型。

这项观察性多中心队列研究纳入425例心脏骤停后入住重症监护室的患者,回顾性分析入院时、骤停后12小时和48小时的血浆p-tau231,并与t-tau比较。p-tau231升高与更差的CPC显著相关(p<0.001),但预后能力中等(AUC入院0.69、12小时0.72、48小时0.71),校正临床协变量后未改善神经功能预后判断。t-tau在各时间点均与更差结局显著相关(p<0.001),48小时校正协变量后显著改善预后(AUC 0.95,95%CI 0.93-0.98,p<0.001),优于临床协变量参考模型(AUC 0.88,95%CI 0.84-0.93)。作者认为t-tau是更强的预测指标,尤其在48小时。

要点

  • 425例心脏骤停后入住ICU患者中,t-tau在48小时校正协变量后显著改善神经功能预后(AUC 0.95,95%CI 0.93-0.98,p<0.001),优于临床参考模型(AUC 0.88,95%CI 0.84-0.93)。
  • p-tau231升高与更差CPC显著相关(p<0.001),但预后能力中等:AUC入院0.69、12小时0.72、48小时0.71。
  • p-tau231在校正临床协变量后未改善神经功能预后判断。
  • t-tau在入院时、12小时和48小时各时间点均与更差结局显著相关(p<0.001)。

适用人群与场景

  • 心脏骤停后入住重症监护室并存活至ICU的成人患者(研究纳入425例)。

研究设计与关键结果

  • 研究类型:观察性多中心队列研究;样本量425例心脏骤停后入住ICU患者;干预/暴露:回顾性分析入院时、骤停后12小时和48小时的血浆p-tau231和t-tau;主要终点:CPC与生物标志物的关联及预后判别能力(AUC)。
  • p-tau231升高与更差CPC显著相关(p<0.001);p-tau231预后能力中等:AUC入院0.69、12小时0.72、48小时0.71;校正临床协变量后未改善神经功能预后判断。
  • t-tau升高在各时间点均与更差结局显著相关(p<0.001);48小时校正协变量后t-tau显著改善神经功能预后(AUC 0.95,95%CI 0.93-0.98,p<0.001),优于临床协变量参考模型(AUC 0.88,95%CI 0.84-0.93)。

证据类型、等级与局限

  • 证据类型:观察性多中心队列研究;原文未报告证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管p-tau231显示中等神经功能预后能力,t-tau是更强的预测指标,尤其在48小时,即使校正临床协变量后仍如此。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We studied the promising Alzheimer biomarker plasma tau phosphorylated at threonine 231 (p-tau231) in a cohort of cardiac arrest patients who survived to intensive care to predict long-term neurological outcomes. We also compared it to total tau (t-tau), which has demonstrated predictive abilities of neurological outcome post-cardiac arrest.

METHODS: This observational multicentre cohort study included 425 patients admitted to intensive care after cardiac arrest. Plasma p-tau231 was retrospectively analysed at admission, 12 and 48 h after cardiac arrest. The association of the Cerebral Performance Category (CPC) with p-tau231 was analysed with a one-way analysis of variance (ANOVA). CPC was modelled using multivariate ordinal logistic regression, and the biomarkers' prognostic performance was assessed by the area under the receiver operating characteristic curve (AUC).

RESULTS: Increasing p-tau231 levels were significantly associated with worse CPC (p < 0.001). P-tau231 showed moderate prognostic abilities (AUC: 0.69 on admission, 0.72 at 12 h, and 0.71 at 48 h) for all patients but did not improve neurological prognostication after adjusting for clinical covariates. Elevated levels of t-tau were significantly associated with a worse outcome at all time points (p < 0.001). T-tau significantly improved neurological prognosis at 48 h after adjusting for covariates (AUC: 0.95, 95 % CI 0.93-0.98, p < 0.001) compared to the clinical covariate reference model (AUC: 0.88, 95 % CI 0.84-0.93).

CONCLUSIONS: Although p-tau231 showed moderate neurological prognostic ability, t-tau was a stronger predictor, particularly at 48 h, even after adjusting for clinical covariates.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Þorgeirsdóttir B, Sievert T, Lybeck A, et al. Plasma phosphorylated tau (p-tau231) and total tau (t-tau) as prognostic markers of neurological outcome after cardiac arrest - a multicentre study. Resuscitation. 2024. PMID: 39637966. doi:10.1016/j.resuscitation.2024.110450

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。